<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00675675</url>
  </required_header>
  <id_info>
    <org_study_id>UCLAP500772484</org_study_id>
    <secondary_id>P50MH077248</secondary_id>
    <nct_id>NCT00675675</nct_id>
  </id_info>
  <brief_title>Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders</brief_title>
  <official_title>TRECC: Neurocognitive Correlates of Behavioral Treatment for Childhood Tic Disorders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>John Piacentini</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of California, Los Angeles</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The study aims to clarify the functional anatomy of key brain circuits associated with
      cognitive control in children and adolescents with chronic tic disorders (CTD) and to compare
      and contrast hypothesized mechanisms related to increased tic control associated with Habit
      Reversal Training, a behavioral treatment that been previously shown to be effective in
      treating CTD. We also seek to better understand the relationship between fMRI and
      quantitative EEG in relevant brain circuits with the hope of establishing EEG as a valid and
      cost-effective marker of treatment responsiveness. A total of 25 subjects will be randomized
      to 10 weeks of Habit Reversal Training (HRT), a behavioral treatment, and 25 to 10 weeks of
      minimal-contact waitlist. Treatment responders will be re-assessed at three months. Waitlist
      nonresponders will be provided with 10 weeks of HRT. Study assessments, including a
      neurocognitive battery and quantitative EEG will be administered at baseline, Wk 5, Wk 10,
      and 3-month follow-up. Neuroimaging (fMRI) will be conducted at baseline and Wk 10.
    </textblock>
  </brief_summary>
  <overall_status>Completed</overall_status>
  <start_date>July 2007</start_date>
  <completion_date type="Actual">December 2011</completion_date>
  <primary_completion_date type="Actual">December 2011</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Basic Science</primary_purpose>
    <masking>Single (Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Clinical Global Impressions - Improvement</measure>
    <time_frame>Wks 0, 5, 10</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Yale Global Tic Severity Scale</measure>
    <time_frame>Wks 0, 5, 10</time_frame>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">53</enrollment>
  <condition>Tic Disorder</condition>
  <arm_group>
    <arm_group_label>Comprehensive Behavioral Intervention for Tics (CBIT)</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Habit Reversal Training (HRT) plus functional assessment/intervention designed to identify and ameliorate environmental triggers for and consequences to tics that might serve to maintain and/or generalize these symptoms</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Minimal Contact Waitlist</arm_group_label>
    <arm_group_type>Other</arm_group_type>
    <description>Bimonthly phone check-in to assess illness severity and maximize subject retention</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Comprehensive Behavioral Intervention for Tics (CBIT)</intervention_name>
    <description>Habit Reversal Training plus functional assessment/intervention designed to identify and ameliorate tic triggers (antecedents) and maintaining consequences.</description>
    <arm_group_label>Comprehensive Behavioral Intervention for Tics (CBIT)</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Minimal Contact Waitlist</intervention_name>
    <description>Bimonthly phone check-in to assess clinical status and enhance subject retention</description>
    <arm_group_label>Minimal Contact Waitlist</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  DSM-IV diagnostic criteria for CTD (CMVT or TS)

          -  Clinical Global Impressions - Severity Score &gt; 3 (moderately ill or worse)

          -  YGTSS Total Score &gt; 14 (or Total Score &gt; 10 if CTD with motor tics only)

          -  Unmedicated or on stable psychotropic medication for at least 6 weeks prior to study
             entry, with no planned changes for duration of study participation

          -  Child is fluent English speaker

          -  Parental Informed Consent and Child Informed Assent.

        Exclusion Criteria:

          -  Total YGTSS Score&gt;35 (Cases above this threshold otherwise eligible will be reviewed
             by Clinical Caseness Panel for potential study participation)

          -  IQ &lt; 80 on the Wechsler Abbreviated Scale of Intelligence (WASI)

          -  Problematic Substance Use or DSM-IV Conduct Disorder in past 3 months

          -  Lifetime DSM-IV diagnosis of PDD, Mania, or Psychotic Disorder

          -  Any serious psychiatric, psychosocial, or neurological condition requiring immediate
             treatment other than that provided in the current study

          -  Previous treatment with four or more sessions of HRT for tics

          -  Contraindication to fMRI scan
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>9 Years</minimum_age>
    <maximum_age>14 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>John Piacentini, Ph.D.</last_name>
    <role>Study Director</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <overall_official>
    <last_name>James McCracken, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of California, Los Angeles</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>University of California, Los Angeles</name>
      <address>
        <city>Los Angeles</city>
        <state>California</state>
        <zip>90024</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>August 2015</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 7, 2008</study_first_submitted>
  <study_first_submitted_qc>May 9, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 12, 2008</study_first_posted>
  <last_update_submitted>August 19, 2015</last_update_submitted>
  <last_update_submitted_qc>August 19, 2015</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 21, 2015</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor-Investigator</responsible_party_type>
    <investigator_affiliation>University of California, Los Angeles</investigator_affiliation>
    <investigator_full_name>John Piacentini</investigator_full_name>
    <investigator_title>Professor in Residence</investigator_title>
  </responsible_party>
  <keyword>Tourette Syndrome</keyword>
  <keyword>Chronic Tic Disorder</keyword>
  <keyword>Tics</keyword>
  <keyword>Behavior Therapy</keyword>
  <keyword>Habit Reversal Training</keyword>
  <keyword>Child</keyword>
  <keyword>Adolescent</keyword>
  <keyword>Neuroimaging</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Disease</mesh_term>
    <mesh_term>Tic Disorders</mesh_term>
    <mesh_term>Tics</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

